LACEY, WA – With nearly a decade of experience in researching and developing novel proprietary botanical ingredients, leading industry supplier UNIGEN USA has now announced the creation of a new Organic Synthesis Department at its Washington State headquarters. In response to concerns about long-term environmental impact, the new department will create synthetic versions of certain natural compounds. Consequently, Unigen will be able to offer to its customers the positive effects of raw ingredients whose source material is in limited supply. These synthesized ingredients will be niche-focused, limited to use in pharmaceutical, cosmeceutical and topical personal care products.
Organic Synthesis Department Head Dr. Padmapriya brings over 30 years of experience in design and organic synthesis of pharmaceutically active molecules. “We will be able to synthesize novel active drug candidates and derivatives based on the natural compounds that we have discovered,” Dr. Padmapriya explained. He commented that he views the new research department as an incredible opportunity to strengthen Unigen’s drug discovery and development efforts as well as create novel cosmetic components.
“We want to make these astounding natural compounds available to the greater public,” said UNIGEN’S President and CEO, Regan Miles. “This fulfills our goal of broadly communicating and distributing the benefits of the botanical sources we are discovering every day.” He added that he is optimistic that this line of development at UNIGEN will open new inroads to the pharmaceutical and cosmeceutical markets, encouraging these sectors to recognize the greater value of natural ingredient sources.
The new Organic Synthesis Department carries on the company’s ongoing track record of cutting edge research and development. UNIGEN’S worldwide offices have 80 employees, 55 of whom are scientists. Contributing to their vast library of novel botanical ingredients, the current facilities include high-throughput screening and cell culture labs, bioprospecting labs and a large scale manufacturing facility.